This item is authorised by the following title:
For transitional provisions relating to the repeal of this instrument, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—February 2026) Instrument 2026.
For transitional provisions relating to the repeal of this instrument, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—February 2026) Instrument 2026.